| |
| | Health Global Access Project (GAP) |
 | | January 26, 2005 (New York) The announcement that Aspen Pharmacare of South Africa has received approval for co-packaged Lamivudine/Zidovudine and Nevirapine through the FDA fast-track marketing approval process represents a glimmer of progress in what still remains an unnecessary, duplicative, costly, delayed, and ultimately flawed U.S. review process. |
 | | The groups are calling for a global investment of US $2 billion in 2006, rising to $7.7 billion in 2010 by all donors, and have calculated the U.S. share as being one-third of the sum needed, or $650 million for 2006, rising to $2.6 billion in 2010. |
 | | January 26, 2005 (New York) At a joint press conference at the opening of the World Economic Forum in Davos, WHO reported progress in the goal of reaching 3 million HIV positive people with combination anti-HIV treatment by the end of 2005, called "3 by 5". |
| www.healthgap.org (3531 words) |
|